Image_3_The Role of Central Complex Neurons in Prey Detection and Tracking in the Freely Moving Praying Mantis (Tenodera sinensis).JPG by Anne Wosnitza (12864746)

Data_Sheet_1_Resting-State Brain Variability in Youth With Attention-Deficit/Hyperactivity Disorder.docx by Soon-Beom Hong (381976)

Table_3_Recovery of synaptic loss and depressive-like behavior induced by GATA1 through blocking of the neuroinflammatory response.XLSX by Koeul Choi (8055968)

Effects of autophagic regulation on cardiac function. by Rong Xiao (130656)

“…Continuous K-H buffer perfusion without medication was used as a negative control. <b>A and B.</b> The left ventricular systolic pressure (LVSP) and the maximal rate of the rise/drop of left ventricular pressure (± dp/dt max) decreased in the hearts perfused with the autophagy activator rapamycin. …”

Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity by Jasmine Nour (14177303)

Induction of abnormal programmed cell death in the nCT brain. by Sunny Li-Yun Chang (275903)

“…<p>A1, A2: Many TUNEL-positive apoptotic cells were found in Ki67-positive germinal zone in the LGE of E12.5 nCT brain (A2). …”

GLI Activators Induce Transcription at the Human <i>TGF-β1</i> Promoter. by Robert L. Furler (313134)

“…<p>The human <i>TGF-β1</i> promoter region was placed into a pGL3-basic luciferase vector. (A) The three GLI binding sites within this region (Sites A, B, and C) were mutated separately or together (WT  =  wild-type <i>TGF-β1</i> promoter phTG5, MUT-A  =  site A mutation, MUT-B  =  sites B/C mutation, MUT-A/B  =  sites A/B/C mutation, pGL3 =  control vector). …”

Distinguishing orthosteric and allosteric effects in Hsp90. by Arun Chandramohan (2813848)

“…<p><b>(A)</b> The absolute difference in numbers of deuterons (y-axis) between the free and ligand bound state is plotted for each pepsin digest fragment listed from the N to C terminus (x-axis) of Hsp90 for each deuterium exchange time point (t = 0.5, 2, 5, 10 min) in a ‘difference plot’. …”

Supplementary Material: Mesenchymal Stem Cells Derived from Human Dental Follicle Modulate the Aberrant Immune Response in Atopic Dermatitis by Noushin Zibandeh (3427640)

Supplementary Material for: Metformin Inhibits Abdominal Aortic Aneurysm Formation through the Activation of the AMPK/mTOR Signaling Pathway by He J. (3923444)

Genetic characterization of p27^kip1 and stathmin in controlling cell proliferation in vivo by Stefania Berton (133705)

In vivo antitumor activity of PHT-427 inhibitor-loaded polymeric nanoparticles in head and neck squamous cell carcinoma by Joaquín Yanes-Díaz (20539584)

Supplementary Material for: Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease by Kikuchi M. (3189621)

DataSheet1_Lipocalin-2 drives neuropsychiatric and cutaneous disease in MRL/lpr mice.docx by Sayra J. Garcia (19748644)

Anticodon sequence determines the impact of mistranslating tRNA^Ala variants by Ecaterina Cozma (11636419)

DataSheet_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.docx by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_3_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_4_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_2_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”